New York, Dec. 7, 2023 /PRNewswire/ -- AiTA Bio, a pioneering bio-MEMS company located in New York City that revolutionized the healthcare technology landscape in the past few decades, has announced the appointment of four industry veterans to its board of directors and advisory team. By committing to innovation and operational excellence, the company is demonstrating its commitment to advancing its groundbreaking augmented biology platform and to continued innovation.
A new member of the board has been appointed:
The following new strategic advisors have been appointed:
The Founders of AiTA Bio, Jacob Menture and Dilan Casanovas, expressed their views on the following:
A brief overview of AiTA Bio Inc. 
As an innovative bio-MEMS technology company, AiTA Bio Inc. is devoted to developing a next-generation drug delivery platform based on intelligent sensing and delivery. This company has developed the first all-in-one insulin pump and continuous glucose monitoring product to treat Type 1 Diabetes Mellitus with the help of its drug delivery chip technology.
The headquarters of AiTA Bio are located in New York City.
There are two locations: New York City and San Diego
Contact information for the media: [email protected]
Please contact [email protected] if you are an investor
AiTA Bio Inc. is the source of this information.
Take advantage of PRN's top stories and curated news delivered directly to your inbox each week by signing up.

Source prnewswire